Nscale seeks about $3.5 billion pre-IPO funding, source says - Reuters
Nscale seeks about $3.5 billion pre-IPO funding, source says Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
Tags
All Coverage
<a href="https://news.google.com/rss/articles/CBMiswFBVV95cUxOa2hLeFBZbVVPaFV6VFpCLUo2U29qaFFDQXV3RUVUV0lIQS1mQ2Z3dUhjREtNRlZ0cjkyVnlzbi1EcTJmRi1JeHJNZDcxRTJEWnNleFlpX1FUdDdhX1ZwdGFENFBMcFdfS1g1WXZRX1ZtOERHcjB4RENuN2MwNjdoTmQtMW10bjBXUEduVnNTOGRUU0YwX2ZBMDV4RDRYUnJ2bklrcDl2N3NFMFJ2REViMWNjYw?oc=5" target="_blank">Nscale seeks about $3.5 billion pre-IPO funding, source says</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Nvidia-backed AI cloud firm Nscale reveals revenue surge in US IPO filing - Reuters
Nvidia-backed AI cloud firm Nscale reveals revenue surge in US IPO filing Reuters
September 18, 2026 at 09:41 PMOura targets $15.62 billion valuation in US IPO, setting stage for fall listings - reuters.com
Oura targets $15.62 billion valuation in US IPO, setting stage for fall listings reuters.com
September 21, 2026 at 12:07 PMIndia's NSE IPO draws over $10 billion, traders eye modest listing pop - reuters.com
India's NSE IPO draws over $10 billion, traders eye modest listing pop reuters.com
September 21, 2026 at 01:21 PMRNA drug developer ADARx seeks $1.74 billion valuation in US IPO - Reuters
RNA drug developer ADARx seeks $1.74 billion valuation in US IPO Reuters
September 21, 2026 at 11:43 AMIndia's biggest bourse lists with small gains after $2.3 billion IPO - Reuters
India's biggest bourse lists with small gains after $2.3 billion IPO Reuters
September 24, 2026 at 06:09 AMAI-based drug developer Basecamp valued at $800 million after $140 million funding round - Reuters
AI-based drug developer Basecamp valued at $800 million after $140 million funding round Reuters
September 23, 2026 at 01:08 PM